Clinical Trials
424 trialsNCT07134556 2026-05-01
ADJUNCT
MedSIR
Phase 2 Withdrawn
NCT02856503 2026-04-17
Effect of High Dose Vitamin D on Cancer Biomarkers and Breast Cancer Tumors
University of Miami
Phase 1/2 Withdrawn
NCT05664893 2026-04-15
CALHYS
Centre Antoine Lacassagne
Phase 1/2 Withdrawn
NCT06229392 2026-03-11
A Study to Evaluate the Intratumoral Influenza Vaccine Administration in Patients With Breast Cancer
Rush University Medical Center
Phase 1 Withdrawn
NCT03868475 2026-03-09
VAPEX
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Phase NA Withdrawn
NCT06710197 2026-03-05
OZM-034
University Health Network, Toronto
Phase 2 Withdrawn
NCT07439432 2026-02-27
Stereotactic Guided Biopsy and Cryoablation
Montefiore Medical Center
Phase NA Withdrawn
NCT05014295 2026-02-24
Patient Recall of Cancer Screening and Diagnosis
Case Comprehensive Cancer Center
Phase NA Withdrawn
NCT06829199 2026-02-19
MK-5890-003
Merck Sharp & Dohme LLC
Phase 2 Withdrawn
NCT06585969 2026-02-12
DISCORDANT
Danish Breast Cancer Cooperative Group
Phase 3 Withdrawn
NCT05512260 2026-02-11
BESTa
Karolinska Institutet
Phase NA Withdrawn
NCT04273555 2026-02-06
Monitoring Early Response to Targeted Therapy in Stage IV HER2+ Breast Cancer Patients With Advanced PET/MR Imaging
University of Alabama at Birmingham
Phase 1/2 Withdrawn
NCT07226102 2026-02-04
Virtual Mental Health Intervention to Address Fear of Progression for Women With High Risk or Stage III-IV Gynecologic or Breast Cancer
City of Hope Medical Center
Phase NA Withdrawn
NCT06613516 2025-12-24
CaptAin
Imperial College London
Phase 2 Withdrawn
NCT05957042 2025-12-10
Pilot Study to Evaluate if Contrast Enhanced Ultrasound (CEUS) Can Predict Treatment Response in Triple Negative Breast Cancer (TNBC) Patients Receiving Combined Chemotherapy and Immune Checkpoint Inhibitors (ICI).
Milton S. Hershey Medical Center
Phase EARLY_PHASE1 Withdrawn
NCT04188119 2025-12-08
IMpALA
The Christie NHS Foundation Trust
Phase 2 Withdrawn
NCT07150767 2025-12-02
A Clinical Study to Explore the Safety, Tolerability, and Efficacy of Recombinant Human nsIL12 Oncolytic Adenovirus Injection (BioTTT001) Combined With Neoadjuvant Treatment for Locally Advanced Breast Cancer
Beijing Bio-Targeting Therapeutics Technology Co., Ltd
Phase 1 Withdrawn
NCT07092475 2025-11-26
The Impact of Intraoperative Methadone on Postoperative Opioid Use
University of Utah
Phase 3 Withdrawn
NCT02825810 2025-11-18
Cervical Motor Control in Long-term Breast Cancer Survivors
Universidad de Granada
Phase NA Withdrawn
NCT05634954 2025-10-23
Study to Evaluate Safety and Dosimetry of [18F]GEH121224 in Patients With Locally Advanced or Metastatic Breast Cancer
GE Healthcare
Phase 1 Withdrawn
NCT04419181 2025-10-14
Feasibility of Chemotherapy De-escalation in Early-Stage HER2 Positive Breast Cancer
University of Rochester
Phase 2 Withdrawn
NCT06884254 2025-10-14
EGC102
EirGenix, Inc.
Phase 3 Withdrawn
NCT03974204 2025-09-26
Analyses of Exosomes in the Cerebrospinal Fluid for Breast Cancer Patients With Suspicion of Leptomeningeal Metastasis.
Centre Oscar Lambret
Phase NA Withdrawn
NCT06597773 2025-09-26
Online Patient Navigation Program for Patients With Breast Cancer
Medicos e Investigadores en la Lucha contra el Cancer de Mama
Phase NA Withdrawn
NCT06672224 2025-09-17
Indocyanine Green Fluoroscopy and SPY Angiography for the Assessment of Lymphatic Structure in Breast Cancer Patients at Risk for Breast Cancer-Related Lymphedema
City of Hope Medical Center
Phase NA Withdrawn
NCT01827969 2025-09-16
USF
Institut Bergonié
Phase NA Withdrawn
NCT06084689 2025-09-02
EMPIRE
Institut Bergonié
Phase 2 Withdrawn
NCT04756765 2025-08-17
Talazoparib Monotherapy in PALB2 Mutation Associated Advanced Breast Cancer
Stanford University
Phase 2 Withdrawn
NCT05678205 2025-07-30
A Clinical Trial of the Safety and Anti-Tumor Activity of AB-201 in Subjects With Advanced HER2+ Solid Tumors
Artiva Biotherapeutics, Inc.
Phase 1/2 Withdrawn
NCT06246786 2025-07-16
Breast/Cyclosporin A/TNBC (Triple Negative Breast Cancer)
The University of Texas Health Science Center at San Antonio
Phase EARLY_PHASE1 Withdrawn
NCT06590558 2025-07-03
Testing the Addition of an Investigational Anti-Cancer Drug, ASTX660 (Tolinapant), to a Usual Chemotherapy Treatment (Eribulin) for Treatment of Advanced Triple Negative Breast Cancer
National Cancer Institute (NCI)
Phase 1 Withdrawn
NCT06852560 2025-06-26
GEM
University of Florida
Phase NA Withdrawn
NCT03941223 2025-06-25
Regional Anesthesia for Breast Surgery
Azienda USL Reggio Emilia - IRCCS
Phase NA Withdrawn
NCT06145399 2025-05-18
A Study of 1 8F-FDHT PET/MRIScans in Women With Breast Cancer
Memorial Sloan Kettering Cancer Center
Phase EARLY_PHASE1 Withdrawn
NCT06978478 2025-05-18
IMETAB6
Queen Mary University of London
Phase NA Withdrawn
NCT01349088 2025-05-02
Investigational Drug in Combination With Two Chemotherapy Drugs in Women With Locally Recurrent or Metastatic Breast Cancer
Thomas Jefferson University
Phase 1/2 Withdrawn
NCT06008301 2025-04-30
Comparing Breast Magnetic Resonance Imaging (MRI) and Contrast-enhanced Mammography (CEM)
Boston Medical Center
Phase NA Withdrawn
NCT04418219 2025-04-29
Breast Cancer Vaccine in Combination With Pembrolizumab for Treatment of Persistent, Recurrent, or Metastatic Breast Cancer
Thomas Jefferson University
Phase 1/2 Withdrawn
NCT06938711 2025-04-22
A Rollover Protocol of Elacestrant, in Combination With Onapristone, for Patients With ER+, PR+, HER2- Advanced or Metastatic Breast Cancer
Context Therapeutics Inc.
Phase 1/2 Withdrawn
NCT05940844 2025-04-09
Study of OB-002 in Patients With Refractory Metastatic Cancer
Orion Biotechnology Polska Sp. z o.o.
Phase 1 Withdrawn
NCT03175666 2025-02-21
QUILT-3.049: NANT Triple Negative Breast Cancer (TNBC) Vaccine: Combination Immunotherapy in Subjects With TNBC Who Have Progressed on or After Anthracycline-based Chemotherapy
ImmunityBio, Inc.
Phase 1/2 Withdrawn
NCT03554109 2025-02-21
TNBC
ImmunityBio, Inc.
Phase 2 Withdrawn
NCT05554211 2025-02-21
Tranexamic Acid Usage in Bilateral Mastectomy to Reduce Post-surgical Drainage
Northwestern University
Phase 2 Withdrawn
NCT05539365 2025-01-29
Dendritic Cell-Based Treatment Plus Immunotherapy for the Treatment of Metastatic or Unresectable Triple Negative Breast Cancer
Roswell Park Cancer Institute
Phase 2 Withdrawn
NCT06341647 2025-01-24
Phase 1 Clinical Trial to Evaluate the Safety and Anti-Tumor Activity of AB-201
GC Cell Corporation
Phase 1 Withdrawn
NCT03473691 2024-12-09
Breast50
University of Virginia
Phase EARLY_PHASE1 Withdrawn
NCT02883361 2024-12-05
MI for AIs
University of Calgary
Phase 2/3 Withdrawn
NCT04160182 2024-11-26
Feasibility and Effectiveness of an Internet-based Intervention to Manage Fatigue in Breast Cancer Survivors
University of Toledo
Phase NA Withdrawn
NCT04232319 2024-11-26
Feasibility and Effectiveness of a Sleep Hygiene Education Program for Sleep Issues in Breast Cancer Survivors
University of Toledo
Phase NA Withdrawn
NCT05427344 2024-11-26
Effectiveness of Aquatic Exercise on Fatigue, Neuropathy and Quality of Life Among Cancer Patients
Tel Aviv University
Phase NA Withdrawn